Impel Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Market Capitalization	0	89	199	-	-
Market Cap Growth	-91.17%	-55.23%	-	-	-
Enterprise Value	110	80	140	1	-37
PE Ratio	-	-0.84	-2.59	-	-
PS Ratio	0.02	7.04	297.65	-	-
PB Ratio	-0.11	-2.02	3.79	-	-
P/FCF Ratio	-0.12	-0.94	-2.98	-	-
P/OCF Ratio	-0.13	-0.95	-3.00	-	-
EV/Sales Ratio	5.26	6.29	209.68	-	-
EV/EBITDA Ratio	-2.02	-0.88	-1.97	-0.03	0.89
EV/EBIT Ratio	-1.94	-0.86	-1.94	-0.03	0.88
EV/FCF Ratio	-1.47	-0.84	-2.10	-0.03	0.97
Debt / Equity Ratio	-1.25	-1.16	0.56	-0.06	-
Debt / EBITDA Ratio	-1.93	-0.57	-0.41	-0.19	-
Debt / FCF Ratio	-1.40	-0.54	-0.44	-0.21	-
Quick Ratio	0.09	3.07	5.61	0.67	4.45
Current Ratio	0.19	3.60	5.93	0.78	4.75
Asset Turnover	0.36	0.11	0.01	0	-
Interest Coverage	-5.00	-6.68	-17.04	-	-
Return on Equity (ROE)	103.10%	1213.10%	-869.10%	41.10%	-
Return on Assets (ROA)	-127.40%	-92.10%	-102.20%	-170.50%	-
Return on Capital (ROIC)	-312.73%	-1183.44%	-87.22%	36.24%	45.33%
Earnings Yield	-20851.12%	-119.42%	-38.56%	-	-
FCF Yield	-23011.77%	-106.74%	-33.58%	-	-
Buyback Yield / Dilution	-0.17%	-60.58%	-2770.31%	-46.57%	-
Total Shareholder Return	-0.17%	-60.58%	-2770.31%	-46.57%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).